PRESS RELEASE – GUINEA – Preliminary results of the JIKI clinical trial to test the efficacy of favipiravir in reducing mortality in individuals infected by Ebola virus in Guinea.
Nzerekore/Dakar/Paris, february 24, 2015
Since December 26, 2014, ALIMA (the Alliance for International Medical Action) and the Network of medical NGO from West and Central Africa are involved in the clinical trial JIKI which aims to test the efficacy of Favipiravir on people infected with Ebola in Guinea. One of the JIKI trials is held at the Ebola treatment center (ETU) run by ALIMA in the prefecture of Nzérékoré.
“Preliminary data from the JIKI clinical trial, which is testing the efficacy of favipiravir in reducing mortality associated with Ebola, provide two important pieces of information:
- absence of efficacy in individuals who arrive at treatment centres with a very high level of viral replication and who already have serious visceral involvement,
- and encouraging signs of efficacy in individuals arriving at treatment centres with a high or moderate level of viral replication, who have not yet developed… lire la suite
For us, a partner is not just another entity with which we work. We call all institutions, national and International NGOs, research laboratories, hospitals, donors, our partners with whom we share the objectives of our projects.
A new operating approach